News Releases

FUJIFILM VisualSonics Introduces Vevo LAZR-X, Next Generation In Vivo Multi-Modal Imaging Platform
FUJIFILM VisualSonics Inc., today announced the launch of its new Vevo LAZR-X, the world’s only customizable imaging platform combining ultra high frequency ultrasound and photoacoustics for animal research applications.
Read more
FUJIFILM VisualSonics Announces Health Canada Clearance for New High-Frequency Ultrasound Device for Humans
FUJIFILM VisualSonics Inc., today announced clearance from Health Canada for its Vevo® MD, the world’s first Ultra High-Frequency (UHF) clinical ultrasound system.
Read more
VisualSonics and Vevo 770 Miro-Ultrasound Featured in The Scientist
TORONTO, CANADA - May 25, 2005 - VisualSonics and the Vevo 770® high-resolution micro-ultrasound is featured in the May 25th, 2005 issue of The Scientist. 
Read more
World's First Real-time, High-Frequency, Encapsulated Transducer Introduced
Toronto, Canada, January 11, 2002 - Today, VisualSonics, the leader in high frequency ultrasound imaging technology, introduced to the world its proprietary new RMVTM technology which offers the first real-time, high frequency encapsulated transducer.
Read more
Second University of Naples Installs World's First Vevo MD from FUJIFILM VisualSonics
Toronto, Canada, June 9, 2016  – FUJIFILM VisualSonics Inc., a world leader in Ultra High Frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., today announced a significant milestone in its history with the installation of the first Vevo® MD Ultra High Frequency (UHF) clinical ultrasound system at the Second University of Naples in Italy.
Read more
FUJIFILM VisualSonics announces 510(K) clearance for the world's first Ultra High Frequency Ultrasound for Humans
Toronto, Canada, April 21, 2016 – FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Vevo® MD, the world’s first Ultra High Frequency (UHF) clinical ultrasound system. With multiple successes in preclinical research over the last decade, theVevo® MD is FUJIFILM VisualSonics’ first foray into the clinical market.
Read more
FUJIFILM VisualSonics Announces CE Mark for Vevo® MD
Toronto, Canada, January 11, 2016 - FUJIFILM VisualSonics Inc., a world leader in ultra high frequency  ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., announces CE mark for the Vevo® MD, the world’s first Ultra High Frequency (UHF) clinical ultrasound system. With multiple successes in preclinical research over the last decade, today marks a major milestone for FUJIFILM VisualSonics as it expands into the clinical market.
Read more
FujiFilm Visualsonics Unveils the Ultimate Pre-Clinical Imaging Experience with the Vevo® 3100 at WMIC Annual Meeting
Toronto, Canada, September 17, 2014 - FUJIFILM VisualSonics will unveil the world’s first one-touch pre-clinical imaging platform, the Vevo® 3100 on September 17 -20 at the World Molecular Imaging Congress Annual Meeting in Seoul, Korea.
Read more
VisualSonics introduces New Cardiovasular Features For Its Vevo 770 Micro-Ultrasound System
Toronto, Ontario. – March 9, 2006 – VisualSonics, the world’s only developer of high-resolution, ultrasound-based micro-imaging systems, announced today new cardiovascular functionalities for its Vevo 770™ high-resolution micro-ultrasound system making the platform more powerful and quantitative for cardiovascular researchers.
Read more
Cover Paper in Journal of Ultrasound in Medicine Features VisualSonics’ Vevo® 770 and MicroMarker™ Contrast Agents for Molecular Quantification of Angiogenesis
Toronto, Canada, October 25, 2007 - VisualSonics would like to congratulate Dr. Andrej Lyshchik and Dr. John Gore of Vanderbilt University Medical Center, Nashville, Tennessee, whose paper using the Vevo 770 and MicroMarker Contrast Agents, was selected as the cover paper for the November 2007 issue of the Journal of Ultrasound in Medicine.
Read more